2. With the huge responsibility of recovering the massive investments in the drug discovery and clinical development
process, brand teams are finding it more and more complex to manage successful launches. The key drivers &
impediments can be summarized as follows:
● Demonstration of real world evidence
and delivering on promised value are
critical to brand favorability and
eventual success
● Increased influence and decision
making beyond the traditional
Prescriber-Payer model
● Support organizations are widely distributed in
terms of function & impact
● Lack of “Design Approach” resulting in sub par
execution and governance process.
● Data silos lead to narrow business understanding
& sub-optimal insights generation
Drivers Impediments
A look at current scenario
3. Challenges in leveraging data analytics systems to power brand launch and lifecycle management
LIFE SCIENCES DATA
KNOWLEDGE &
ACQUISITION
DOMAIN BASED DATA
BLENDING & STORAGE
DESCRIPTIVE AND
PRESCRIPTIVE ANALYSIS
ADVANCED &
PREDICTIVE
ANALYTICS
PRESENTATION
& ACTION
Bigger challenges
4. Services oriented delivery
Cost & time intensive deployments
Lack of domain expertise
Limited flexibility & scalability
Common
Challenges
Expensive Contracts
Resource Dependence
Misalignment with business
processes & goals
Resulting
Impact
What can common obstacles lead to?
5. DDSTMBrandEXTM is a unified launch planning and tracking solution that provides a 360o view of the landscape and aids in
strategic planning, tactical corrections and decision making across functions to drive brand launch success.
The Magic Potion - DDSTMBrandEXTM
6. Cloud based data
ingestion and management
KNIME Libraries to power advanced
analytics workflows
Hyperbase advanced
business intelligence tool
Key components of DDSTMBrandEXTM
7. A true 360o approach that tracks and predicts key measures at a granular level.
Product awareness & perception
Intent to prescribe & use
Promotional reach and frequency
Product awareness and
perception
Persistence & compliance rates
Willing to try
Tier Status | Restrictions
Co-pay and out of pocket costs
% of KOLs reached
% of KOLs who are advocates of the drug
KOLs involvement
Disease awareness
Level of disease burden perception
(Social) media buzz around the drug
% patients aware of disease
% patients diagnosed
% patients seeking treatment
Physician
Patient
Payor
KOL
Public Disease Policy
Measure, Predict and Act to disrupt Pharmaceutical Brand Management with DDSTM
BrandEXTM
8. Productized offerings drive up
to a 50% faster & cheaper
solution
Infinite customization to meet
the unique needs of each
brand/ portfolio
Significantly lower Total Cost
of Ownership (TCO) through
a global delivery model
Key benefits Brand Management With DDSTMBrandEXTM
9. US Office
D Cube Analytics Inc.1320 Tower Road,
Schaumburg, Illinois 60173, USA
Contact
Email
info@dcubenalytics.com
Ready to test drive
the new paradigm?
Request A Demo
Contact
Phone
US : +1 847.807.4996